Video - 14 January 2011

Attana Cell Biosensor

Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, the Attana Cell 200 minimizes costs and increases success during clinical trials. (produced by TTV AB)

License:: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:: .mp4
Length:: 1:24

Download

Topics

Medical research

Related content

20 September 2011 09:00
Attana AB and Layerlab AB sign global distribution agreement

Attana and Layerlab announced today that they have signed a global distribution agreement under which Attana will distribute memLAYER ™ for utilization together with Attana’s QCM biosensors. With biosensor users in mind, both Attana and Layerlab can now offer the market new and improved application methods.
11 October 2011 10:19
Tecan and Attana extend distribution agreement

Stockholm, Sweden, October 11, 2011- Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe.
22 December 2010 03:00
Maximising Drug Discovery Research- Interview with Attana CEO, Teodor Aastrup

Attana is one of the sponsor companies at the upcoming marcus evans Discovery Summit 2011 in Cannes, France, 21-23 March. Prior to the event marcus evans and Aastrup discuss in this interview the role biologics can play in speeding up drug discovery and subsequent stages.
22 September 2010 09:34
Fight against cancer - Attana's collaborator interviewed

Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do.
5 July 2010 09:49
Attana's Story told by CEO and co-founder Dr. Teodor Aastrup

When we founded Attana in 2002, we had a dream of creating a tool that could mimic reality. We were set to do this by developing an instrument capable of measuring biological interactions exactly as the actual events in the human body.
16 November 2011 09:32
Find out: Why bridge the existing gap between biochemical and cell based assays?

One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.
2 March 2012 09:15
The combination between biochemical and cell based assay- Attana appears in International Trade News

Long before pharmaceutical substances are tried on animals or human beings, they are carefully tested in simulated environments. Attana's biosensors characterize molecular interactions exactly as they would occur in the human body, the company offers its clients relevant information before further tests are carried out.
17 April 2012 09:00
A New Generation of Cell-Biosensors targeting Cancer

Read the latest article in IPT (Innovations in Pharmaceutical Technology) about the new generation cell-biosensors that enables studies in a more relevant cellular environment to better understand drug-cell interactions for development of new pharmaceuticals. A model like this using bio-sensors could significantly reduce the costs and time-scales involved in the development of the next generation
8 February 2011 10:33
Inspiration builds motivation

As any sports enthusiast knows, inspiration creates motivation for success. On a personal level, you don’t have to be inspired to get up at six in the morning to jog before work (you just need a desire to stay healthy), but if you are, you will not only notice that the sky is blue and the way the gravel crunches nicely under your shoes as you run; you will also look forward to...

Attana Cell Biosensor

Topics

Categories

Related media

Related content